Literature DB >> 11262181

Rho GTPases are involved in the regulation of NF-kappaB by genotoxic stress.

R Gnad1, B Kaina, G Fritz.   

Abstract

A common cellular response to genotoxic agents and inflammatory cytokines is the activation of NF-kappaB. Here, we addressed the question of whether small GTPases of the Rho family are involved in the stimulation of NF-kappaB signaling by genotoxic agents or TNFalpha in HeLa cells. Inhibition of isoprenylation of Rho proteins by use of the HMG-CoA reductase inhibitor lovastatin attenuated UV-, doxorubicin-, and TNFalpha-induced degradation of IkappaBalpha as well as drug-stimulated DNA binding activity of NF-kappaB. Furthermore, NF-kappaB-regulated gene expression stimulated by either UV irradiation or treatment with TNFalpha was abrogated by lovastatin pretreatment. This indicates that isoprenylated regulatory proteins participate in the regulation of NF-kappaB by DNA-damaging agents as well as by TNFalpha. Specific blockage of Rho signaling by Clostridium difficile toxin B attenuated UV- and doxorubicin-induced activation of NF-kappaB, but did not affect stimulation of NF-kappaB by TNFalpha. Obviously, signaling to NF-kappaB by genotoxic and nongenotoxic stimuli occurs via different molecular mechanisms, either involving Rho GTPases or not. Based on the data, we suggest Rho GTPases to be essentially required for genotoxic stress-induced signaling to NF-kappaB. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11262181     DOI: 10.1006/excr.2001.5165

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Cdc42 GTPases facilitate TNF-α-mediated secretion of CCL2 from peripheral nerve microvascular endoneurial endothelial cells.

Authors:  Kelly A Langert; Cynthia L Von Zee; Evan B Stubbs
Journal:  J Peripher Nerv Syst       Date:  2013-09       Impact factor: 3.494

2.  Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression.

Authors:  C Bourgier; V Haydont; F Milliat; A François; V Holler; P Lasser; J Bourhis; D Mathé; M-C Vozenin-Brotons
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells.

Authors:  Galina V Shurin; Irina L Tourkova; Michael R Shurin
Journal:  J Immunother       Date:  2008-06       Impact factor: 4.456

4.  Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.

Authors:  J Damrot; T Nübel; B Epe; W P Roos; B Kaina; G Fritz
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

5.  SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.

Authors:  Nathan J Schuld; Andrew D Hauser; Adam J Gastonguay; Jessica M Wilson; Ellen L Lorimer; Carol L Williams
Journal:  Cell Cycle       Date:  2014-01-16       Impact factor: 4.534

6.  Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

Authors:  Sarah E James; Mayisha Dunham; Monica Carrion-Jones; Alexander Murashov; Qun Lu
Journal:  Neurotoxicology       Date:  2010-01-08       Impact factor: 4.294

7.  Intestinal exposure to PCB 153 induces inflammation via the ATM/NEMO pathway.

Authors:  Matthew C Phillips; Rishu Dheer; Rebeca Santaolalla; Julie M Davies; Juan Burgueño; Jessica K Lang; Michal Toborek; Maria T Abreu
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-29       Impact factor: 4.219

8.  δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.

Authors:  Asaf A Qureshi; Julia C Reis; Nilofer Qureshi; Christopher J Papasian; David C Morrison; Daniel M Schaefer
Journal:  Lipids Health Dis       Date:  2011-02-28       Impact factor: 3.876

9.  Construction of predictive promoter models on the example of antibacterial response of human epithelial cells.

Authors:  Ekaterina Shelest; Edgar Wingender
Journal:  Theor Biol Med Model       Date:  2005-01-12       Impact factor: 2.432

10.  DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions.

Authors:  Veenu Tripathi; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Springerplus       Date:  2014-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.